New diabetes targets

New diabetes targets

Company Product Target Status
sanofi-aventis Rimonabant (A) Cannabinoid CB1 receptor Ph III
MacroGenics

Read the full 177 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE